🇺🇸
United States · US · US:0955-1731_0bef8406-8dab-0ad0-e063-6394a90a60d0
OXALIPLATIN
In shortageOrange BookUNIISPLATC L01XA03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerWinthrop U.S, a business of sanofi-aventis U.S. LLC
CountryUS (United States)
ATC codeL01XA03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1109551731101 VIAL, GLASS in 1 CARTON (0955-1731-10) / 10 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
04ZR38536J
OXALIPLATIN
RxCUI 32592
Orange Book
N021759
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Oxaliplatin Injection
Raw payload (JSON)
{
"unii": {
"unii": "04ZR38536J",
"rxcui": "32592",
"inchikey": "ZROHGHOFXNOHSO-BNTLRKBRSA-L",
"display_name": "OXALIPLATIN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"1ac38523-480b-4c0f-97a1-7dfa1432923c": {
"match": "brand_token",
"title": "OXALIPLATIN INJECTION, SOLUTION [SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.]",
"spl_version": "2",
"published_date": "2026-04-15"
}
},
"productid": "0955-1731_0bef8406-8dab-0ad0-e063-6394a90a60d0",
"productndc": "0955-1731",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"orange_book": {
"appl_no": "021759",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "001",
"approval_date": "Jan 31, 2005"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "002",
"approval_date": "Jan 31, 2005"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "003",
"approval_date": "Nov 17, 2006"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "OXALIPLATIN",
"shortage_reason": "Oxaliplatin Injection",
"shortage_status": "current",
"proprietary_name": "OXALIPLATIN",
"active_ingred_unit": "mg/mL",
"application_number": "NDA021759",
"marketing_category": "NDA AUTHORIZED GENERIC",
"nonproprietary_name": "oxaliplatin",
"start_marketing_date": "20150901",
"active_numerator_strength": "5"
}Related drugs
Other records sharing ATC code L01XA03.
- FIEloxatinsanofi-Aventis Oy
- FIEloxatinsanofi-Aventis Oy
- GBEloxatin 100mg powder for solution for infusion vialsSanofi
- GBEloxatin 100mg/20ml concentrate for solution for infusion vialsSanofi
- GBEloxatin 200mg/40ml concentrate for solution for infusion vialsSanofi
- BEEloxatin 5 mg/mlSanofi Belgium
- BEEloxatin 5 mg/mlSanofi Belgium
- BEEloxatin 5 mg/mlSanofi Belgium
Access this data programmatically
Query OXALIPLATIN and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.